Correction to “Exploring the impact of ursodeoxycholic acid therapy on COVID‐19 in a real‐word setting”

Documenti analoghi

• Association between monoclonal antibody therapy, vaccination, and longer‐term symptom resolution after acute COVID‐19
  di: Samantha C. Roberts, et al.
  Pubblicazione: (2024)
• Identifying COVID‐19 subtypes by single‐sample gene set enrichemnt analysis and providing guidance for sensitive drug selection
  di: Nan Xiong, et al.
  Pubblicazione: (2024)
• Exploring viral infections' role in Kawasaki disease onset: A study during the COVID‐19 pandemic
  di: Taku Ishii, et al.
  Pubblicazione: (2024)
• Exploring the incidence of peripheral arterial occlusive disease following COVID‐19 infection: A retrospective cohort study
  di: Liang‐Tsai Yeh, et al.
  Pubblicazione: (2024)
• Correction to “Serum‐Derived Bovine Immunoglobulin Treatment in COVID‐19 Is Associated With Faster Resolution of Symptoms: A Randomized Pilot Clinical Trial”
  Pubblicazione: (2025)